Article thumbnail

An agonist sensitive, quick and simple cell-based signaling assay for determination of ligands mimicking prostaglandin E2 or E1 activity through subtype EP1 receptor: Suitable for high throughput screening

By Annirudha J Chillar, Parastoo Karimi, Kathy Tang and Ke-He Ruan
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3042985
Provided by: PubMed Central

Suggested articles

Citations

  1. (2002). A: Augmentation of receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin receptor subtype EP3 in a Gbetagamma subunit-independent manner. Biochem Biophys Res Commun
  2. (2008). A: Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.
  3. (2008). AJ: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.
  4. (2009). Antioxidant and anti-inflammatory activity of pine pollen extract in vitro. Phytother Res
  5. (2008). Badve SS: Prostanoid receptor EP1 expression in breast cancer. Mod Pathol
  6. (2000). Baskett TF: In the arms of morpheus: the development of morphine for postoperative pain relief.
  7. (2008). Cabrini G: Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol
  8. (2005). Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov
  9. (2000). Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium
  10. (2006). Comparison of antiinflammatory activities of six Curcuma rhizomes: a possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. eCAM
  11. (2007). de Souza IA, do Nascimento SC, Leite SP: Indigoferasuffruticosa: an alternative anticancer therapy. eCAM
  12. (2005). DM: Medicinal benefits of green tea, part II: review of anticancer properties.
  13. (2004). Down regulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut
  14. (2004). Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines andexpression of estrogen receptor alpha gene.
  15. (2007). EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
  16. (2005). Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res
  17. (2005). Hla T: The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. Cancer Res
  18. (1983). Hoshi A: Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man.
  19. (2008). I: New aspect of antiinflammatory action of lipo-prostaglandin E1 in the management of collagen diseases-related skin ulcer. Rheumatol Int
  20. (2005). Leadlay PF: Combinatorial biosynthesis of reduced polyketides. Nat Rev Microbiol
  21. (1993). Lipo-PGEl A New Lipid-Encapsulated Preparation Of Prostaglandin El: Placebo-And Prostaglandin El-Controlled Multicentric Trials In Patients With Diabetic Neuropathy And Leg Ulcers. Prostaglandins
  22. (2001). Marked hypotensive and blood flow-increasing effects of a new lipo-PGE (lipo-AS013) due to vascular wall targeting.
  23. (2008). Munro MH: Evolving Trends in the Dereplication of Natural Product Extracts: New Methodology for Rapid, Small-Scale Investigation of Natural Product Extracts.
  24. (2006). Paraskeva C: Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res
  25. (2008). Prostaglandin E1 inhibits IL6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation.
  26. (2007). S: Anti-Inflammatory activity of the methanol extract of moutan cortex in LPS-activated Raw264.7 cells. eCAM
  27. (2009). Screening of bioactive compounds from moutan cortex and their anti-inflammatory activities in rat synoviocytes. eCAM
  28. (2009). Svensson KM: Inhibition of cyclooxygenase-2 and EP1 receptor antagonism reduces human colonic longitudinal muscle contractility in vitro. Prostaglandins Other Lipid Mediat
  29. (2004). The Role of Natural Product Chemistry in Drug Discovery.
  30. (1994). Treatment of the peripheral vascular diseases with prostaglandin. Nippon Rinsho
  31. (2007). Zhao RC: Effects of Human Mesenchymal Stem Cells on the Differentiation of Dendritic Cells from CD34 Cells. Stem Cells And Development

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.